Join the 200th Anniversary Celebration

Perspective

Going Dutch — Managed-Competition Health Insurance in the Netherlands

Alain C. Enthoven, Ph.D., and Wynand P.M.M. van de Ven, Ph.D.

N Engl J Med 2007; 357:2421-2423December 13, 2007

Article

Twenty-five years ago, the health care system of the Netherlands was operating under top-down cost-containment policies, such as regulation of doctors' fees and hospital budgets, that were widely criticized for lacking incentives for efficiency and innovation. In 1986, the Dekker Committee, an independent group appointed by the Dutch government to seek a solution, recommended market-oriented reform within the context of a national health insurance system. But before the concept could be implemented, a host of adequate systems had to be developed — systems of risk equalization, of product classification and medical pricing to give providers appropriate incentives for efficiency, of outcome and quality measurement to permit the development of fully specified contracts between insurers and providers and to prevent competition focused only on price, and of information sharing with consumers about the prices and quality of insurers and providers. Moreover, successful implementation required an adequate governance structure and an effective competition policy. For the next 20 years, successive governments consistently worked to realize the preconditions for managed competition.

Finally, on January 1, 2006, the Dutch government enacted the Health Insurance Act (HIA), under which every person who legally lives or works in the Netherlands is obliged to buy, from a private insurance company, individual health insurance whose benefits are specified by law (see tableKey Elements of the Dutch Health Care System.). Penalties for failure to enroll include back payments for premiums that would have been charged had enrollment occurred on time. To date, about 98.5% of eligible Dutch people have enrolled.

The law covers care by general practitioners and specialists, as well as pharmaceuticals and hospital care (for up to 1 year). In addition, the Exceptional Medical Expenses Act provides everyone with coverage for potential needs such as long-term care and hospitalization beyond 1 year. The HIA describes the standardized basic benefits package in terms of “functions of care,” rather than “providers of care” — for instance, “rehabilitation care,” rather than care delivered by rehabilitation institutions.

About 15 competing insurers, some for-profit and others not-for-profit, are intended to be prudent buyers of care. They compete on the basis of premiums, service, and the quality of care offered by their contracted providers, as well as on the premiums and benefits of any supplementary health insurance they provide. The insurers may contract, through various types of arrangements, with independent doctors and hospitals, or they may provide care directly, through their own facilities and staff.

Although the insurers and providers are predominantly private businesses, they are heavily regulated. But the government intends to relax regulatory constraints gradually and to turn more and more of the care over to the competitive market.

Inpatient services provided by hospitals and physicians are paid for mostly on the basis of Diagnostic Treatment Combinations (DTCs), for which prospectively fixed amounts are charged per episode of care. For 20% of the 35,000 DTCs, insurers and hospitals are allowed to negotiate prices freely and to contract selectively. The government intends to increase this proportion to 70% if certain preconditions are fulfilled — for example, if the predictive accuracy of the risk-equalization model is improved. The government reinsures and shares financial risk with insurers, but it intends to shift more risk to the insurers over time, as risk equalization is improved.

All individuals must pay an income-related contribution (6.5% of the first €30,000 in annual income) to the Risk Equalization Fund. Employers are obliged to compensate their employees for these contributions, but this is then taxable income for employees. In addition, all adults must pay a community-rated premium (i.e., the same price for the same benefits, regardless of their own level of health) to the insurer of their choice. Insurers set their own prices. Households receive a care allowance if the average community-rated premium exceeds a certain proportion of their income (4%, for single adults). Two thirds of all households currently receive a care allowance. Because they must pay for whatever portion is not covered by such an allowance, adult consumers must pay the full difference if they choose a higher-priced plan. The government pays for all costs incurred by children.

For each “basic insurance product,” insurers are obliged to accept every applicant. People may choose to buy supplemental insurance covering care that is not included in the mandatory basic insurance — for instance, dental care, physical therapy, eyeglasses, and cosmetic surgery. For supplementary health insurance, however, there are no restrictions on premium rates and no requirement that insurers accept all applicants. Since 93% of insured people in the Netherlands have chosen to buy supplemental insurance, insurers have a substantial opportunity to select risks.

Risk equalization is an essential part of this system. The expected expense associated with each enrollee is estimated on the basis of predictive modeling, and the Risk Equalization Fund pays appropriately more to insurers whose enrollees' care is predicted to cost more than average, while insurers whose enrollees' care is expected to cost less than average must pay the fund. Thus, insurers' incentives for risk selection are substantially reduced but not entirely removed.

Insurers are meant to be customer-driven organizers of care for the people they insure, similar to American health maintenance organizations. To improve care management, insurers are increasingly using many techniques, including protocols, provider selection, incentive contracting, and standardized approaches to disease management.

The Dutch system is still a work in progress, and substantial problems remain. First, the risk-equalization model requires further improvement and continuing adjustment. Second, since the Dutch combine income-related subsidies for health insurance with similar payments for housing, child care, and scholarships, a high percentage of each extra euro earned reduces the earner's subsidy, leaving people with little incentive to earn more money. Third, the existence of supplemental insurance with risk rating and without open enrollment may leave too large an opportunity for insurers to profit from risk selection. Finally, the current focus is on insurers, but the promise of this model lies in competition among delivery systems — which the insurers are now creating.

The “Dutch model” was actually first designed and proposed for the United States,1 and similar proposals are alive today.2 There are already some good U.S. models of responsible consumer choice and competition that have worked well for decades; these include the Federal Employees Health Benefits Program, the Wisconsin Employee Trust Fund, the California Public Employees' Retirement System, and the employee benefit programs of Wells Fargo Bank, the University of California, and Stanford University, among others. Experience in these systems shows that people migrate to what they see as the best value for their money, and they are satisfied with their choices. The implementation of a Dutch model in the United States could extend its best practices to the whole population.

There are many U.S. physician organizations — more than 460 with 100 or more physicians apiece — that are capable of owning and operating their own health plans.3 This kind of model would be well suited to U.S. cultural preferences for individual choice, multiple competing approaches, local control, and pluralism. It is compatible with the proposal put forward by the American Medical Association in 2004, which involved offering tax credits for the purchase of portable, individually owned health insurance.4

A U.S. version of the Dutch model would provide an opportunity for U.S. physician organizations to form their own health plans and present themselves directly to the consumer market, freeing them from control by large, remote, third-party insurance carriers and from the maddening complexity of having to deal with 15 to 30 different insurance companies and self-insured employers, each with its own payment criteria and plan designs. Medical groups could build their own customer base and loyalties. They could design their own coverage criteria, incentive schemes, utilization management, and other features. Surveys show that Kaiser Permanente physicians, for instance, are the most satisfied doctors in California5 — doubtless in substantial part because they deal with a single insurance plan that is answerable to the medical group and generally defines a covered service as one performed or prescribed by a Permanente doctor.

A U.S. Dutch model would also represent an opportunity for consumers to have the physician organization of their choice and stay with it for generations, whatever their job status, as long as they did not move away from the service area. Such a system would offer many benefits: the availability of complete longitudinal medical records, built-in incentives for the physician organization to make long-term investments in members' health, and an opportunity for consumers to save money by joining a less costly, more efficient delivery system. Now that health care reform has once again climbed toward the top of the national agenda, we believe that such an approach would be the best choice for the United States.

Source Information

Dr. Enthoven is a professor of management at the Stanford University Graduate School of Business, Stanford, CA. Dr. van de Ven is a professor of health insurance in the Department of Health Policy and Management, Erasmus University, Rotterdam, the Netherlands.

References

References

  1. 1

    Enthoven AC. Consumer-choice health plan. N Engl J Med 1978;298:650-8, 709
    Full Text | Web of Science | Medline

  2. 2

    Quality, affordable health care for all: moving beyond the employer-based health-insurance system. Washington, DC: Committee for Economic Development, October 15, 2007.

  3. 3

    Shortell SM, Schmittdiel J. Prepaid groups and organized delivery systems: promise, performance, and potential. In: Enthoven AC, Tollen, LA, eds. Toward a 21st century health system: the contributions and promise of prepaid group practice. San Francisco: Jossey-Bass, 2004.

  4. 4

    Palmisano DJ, Emmons DW, Wozniak GD. Expanding insurance coverage through tax credits, consumer choice, and market enhancements: the American Medical Association proposal for health insurance reform. JAMA 2004;291:2237-2242
    CrossRef | Web of Science | Medline

  5. 5

    Rittenhouse DR, Grumbach K, O'Neil EH, Dower C, Bindman A. Physician organization and care management in California: from cottage to Kaiser. Health Aff (Millwood) 2004;23:51-62
    CrossRef | Web of Science | Medline

Citing Articles (20)

Citing Articles

  1. 1

    Ine Borghans, Rudolf B. Kool, Ronald J. Lagoe, Gert P. Westert. (2012) Fifty ways to reduce length of stay: An inventory of how hospital staff would reduce the length of stay in their hospital. Health Policy
    CrossRef

  2. 2

    Onyebuchi A. Arah, Bastiaan Roset, Diana M. J. Delnoij, Niek S. Klazinga, Karien Stronks. (2011) Associations between technical quality of diabetes care and patient experience. Health Expectationsno-no
    CrossRef

  3. 3

    Sanne M. van der Star, Bernard van den Berg. (2011) Individual responsibility and health-risk behaviour: A contingent valuation study from the ex ante societal perspective. Health Policy 101:3, 300-311
    CrossRef

  4. 4

    Okma, Kieke G.H., Marmor, Theodore R., Oberlander, Jonathan, . (2011) Managed Competition for Medicare? Sobering Lessons from the Netherlands. New England Journal of Medicine 365:4, 287-289
    Full Text

  5. 5

    Howard Waitzkin, Joel Yager, Richard Santos. (2011) Advancing the business creed? The framing of decisions about public sector managed care. Sociology of Health & Illnessno-no
    CrossRef

  6. 6

    Lieke H. H. M. Boonen, Frederik T. Schut. (2011) Preferred providers and the credible commitment problem in health insurance: first experiences with the implementation of managed competition in the Dutch health care system. Health Economics, Policy and Law 6:02, 219-235
    CrossRef

  7. 7

    Lieke H. H. M. Boonen, Bas Donkers, Frederik T. Schut. (2011) Channeling Consumers to Preferred Providers and the Impact of Status Quo Bias: Does Type of Provider Matter?. Health Services Research 46:2, 510-530
    CrossRef

  8. 8

    Samantha A. Adams. (2011) Sourcing the crowd for health services improvement: The reflexive patient and “share-your-experience” websites. Social Science & Medicine 72:7, 1069-1076
    CrossRef

  9. 9

    Eui-Chul Shin, Geum-Ja Im, Eunw-Han Lee, Yun-Hwan Lee. (2011) Reviewing Efficiency Strategy of Long-term Care System. Korean Journal of Health Policy and Administration 21:1, 115-131
    CrossRef

  10. 10

    Soon-Im Huh, Sue-Hyung Lee. (2011) Unmet Health Care Needs and Associated Factors among Patients with Hypertension and Those with Diabetes in Korea. Korean Journal of Health Policy and Administration 21:1, 1-22
    CrossRef

  11. 11

    Sonja Wendel, Judith D de Jong, Emile C Curfs. (2011) Consumer evaluation of complaint handling in the Dutch health insurance market. BMC Health Services Research 11:1, 310
    CrossRef

  12. 12

    Margaret R. Helton, Lauren W. Cohen, Sheryl Zimmerman, Jenny T. van der Steen. (2011) The Importance of Physician Presence in Nursing Homes for Residents with Dementia and Pneumonia. Journal of the American Medical Directors Association 12:1, 68-73
    CrossRef

  13. 13

    Christopher Millett, Arpita Chattopadhyay, Andrew B. Bindman. (2010) Unhealthy Competition: Consequences of Health Plan Choice in California Medicaid. American Journal of Public Health 100:11, 2235-2240
    CrossRef

  14. 14

    Colleen M. Flood, Amanda Haugan. (2010) Is Canada odd? A comparison of European and Canadian approaches to choice and regulation of the public/private divide in health care. Health Economics, Policy and Law 5:03, 319-341
    CrossRef

  15. 15

    THOMAS C. BUCHMUELLER. (2009) Consumer-Oriented Health Care Reform Strategies: A Review of the Evidence on Managed Competition and Consumer-Directed Health Insurance. Milbank Quarterly 87:4, 820-841
    CrossRef

  16. 16

    Lieke H. H. M. Boonen, Frederik T. Schut, Bas Donkers, Xander Koolman. (2009) Which preferred providers are really preferred? Effectiveness of insurers’ channeling incentives on pharmacy choice. International Journal of Health Care Finance and Economics 9:4, 347-366
    CrossRef

  17. 17

    P. Ryan, S. Thomas, C. Normand. (2009) Translating Dutch: challenges and opportunities in reforming health financing in Ireland. Irish Journal of Medical Science 178:3, 245-248
    CrossRef

  18. 18

    Ofke S. van Boxel, Matthijs P. Hagenaars, André J.P.M. Smout, Peter D. Siersema. (2009) Sociodemographic Factors Influence Use of Proton Pump Inhibitors Among Users of Nonsteroidal Anti-Inflammatory Drugs. Clinical Gastroenterology and Hepatology 7:8, 855-861
    CrossRef

  19. 19

    O. S. van BOXEL, M. P. HAGENAARS, A. J. P. M. SMOUT, P. D. SIERSEMA. (2009) Socio-demographic factors influence chronic proton pump inhibitor use by a large population in the Netherlands. Alimentary Pharmacology & Therapeutics 29:5, 571-579
    CrossRef

  20. 20

    Michael J. Pentecost. (2008) The New Dutch Reformation. Journal of the American College of Radiology 5:4, 544-545
    CrossRef